Skip to main content
. 2016 May 23;2016(5):CD007126. doi: 10.1002/14651858.CD007126.pub3

Fletcher 1997.

Methods Randomized, double‐blind, active‐ and placebo‐controlled
Medications administered at skin closure (and repeated every 6 h x 48 h)
Participants Type of surgery: surgery of one herniated lumbar disc
Propacetamol group
Entered/completing: 15/14
Age (mean, SD): 41.8 ± 2.7
Sex (male, %): 53
Ketoprofen group
Entered/completing: 15/14
Age (mean, SD): 49.7 ± 2.9
Sex (male, %): 53
Placebo group
Entered/completing: 15/15
Age (mean, SD): 41.8 ± 2.4
Sex (male, %): 60
Interventions Intervention: 2 g propacetamol in 125 ml dextrose 5%
Control: ketoprofen 50 mg
Control: combination of ketoprofen with propacetamol (not included in our analysis)
Placebo: 125 ml dextrose 5%
Outcomes Pain intensity at rest and with movement (VAS)
Sedation (4‐point categorical scale)
Source of funding Not reported
Were treatment groups comparable at baseline? Yes: demographics; preoperative pain; duration of surgery
Details of preoperative pain Incidence of preoperative leg and/or back pain similar between groups. Mean severity of preoperative pain similar (ranged from 42 to 51/100) between groups.
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Before the study began, a random number table was used to generate a randomized schedule specifying the group to which each patient would be assigned upon entry into the trial
Allocation concealment (selection bias) Unclear risk Not described
Blinding (performance bias and detection bias) 
 All outcomes Low risk All drugs were administered IV after dilution in 125 ml dextrose 5% labeled with the randomization number of the participant. Participants in all groups received 2 injections to assure blinding.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Low attrition rate balanced amongst groups
Selective reporting (reporting bias) Low risk All outcomes from Methods section reported in Results section
Size High risk Fewer than 50 participants per arm of the study (15 propacetamol, 15 ketoprofen, 15 placebo)